Adaptimmune Therapeutics PLC reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Abingdon, Oxfordshire
SEC filing record 1 source field available
Fiscal year end
31 December
Adaptimmune Therapeutics PLC has filed 808 SEC EDGAR filings since 02 Oct 2014

SEC filing history

Showing 476-500 of 808 matching filings.

Per page
25
Current page
20
SC 13G/A File 005-88833

ADAPTIMMUNE THERAPEUTICS PLC

Filing date
10 Jan 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
08 Jan 2019
Reporting date
04 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
08 Jan 2019
Reporting date
04 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
08 Jan 2019
Reporting date
04 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
08 Jan 2019
Reporting date
04 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
08 Jan 2019
Reporting date
04 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37368

8-K

Filing date
07 Jan 2019
Reporting date
07 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
20 Dec 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
19 Dec 2018
Reporting date
17 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37368

8-K

Filing date
12 Dec 2018
Reporting date
10 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
03 Dec 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
16 Nov 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37368

8-K

Filing date
06 Nov 2018
Reporting date
06 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37368

8-K

Filing date
22 Oct 2018
Reporting date
20 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
18 Oct 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88833

ADAPTIMMUNE THERAPEUTICS PLC

Filing date
10 Oct 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-88833

AMENDMENT NO. 4

Filing date
10 Oct 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
03 Oct 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
02 Oct 2018
Reporting date
01 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
01 Oct 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-88833

NEW ENTERPRISE ASSOCIATES 14, L.P. / ADAPTIMMUNE THERAPEUTICS PLC -- SCHEDULE 13

Filing date
17 Sep 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
10 Sep 2018
Reporting date
07 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
10 Sep 2018
Reporting date
07 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
10 Sep 2018
Reporting date
07 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .